본문 바로가기
KERD
논문KCI 등재

Effect of vitamin C on azoxymethane (AOM)/dextran sulfate sodium (DSS)-induced colitis-associated early colon cancer in mice

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

BACKGROUD/OBJECTIVES: The objective of this study was to investigate the effects of vitamin C on inflammation, tumor development, and dysbiosis of intestinal microbiota in an azoxymethane (AOM)/dextran sulfate sodium (DSS)-induced inflammation-associated early colon cancer mouse model. MATERIALS/METHODS: Male BALB/c mice were injected intraperitoneally with AOM [10 mg/kg body weight (b.w)] and given two 7-d cycles of 2% DSS drinking water with a 14 d inter-cycle interval. Vitamin C (60 mg/kg b.w. and 120 mg/kg b.w.) was supplemented by gavage for 5 weeks starting 2 d after the AOM injection. RESULTS: The vitamin C treatment suppressed inflammatory morbidity, as reflected by disease activity index (DAI) in recovery phase and inhibited shortening of the colon, and reduced histological damage. In addition, vitamin C supplementation suppressed mRNA levels of pro-inflammatory mediators and cytokines, including cyclooxygenase-2, microsomal prostaglandin E synthase-2, tumor necrosis factor-α, Interleukin (IL)-1β, and IL-6, and reduced expression of the proliferation marker, proliferating cell nuclear antigen, compared to observations of AOM/DSS animals. Although the microbial composition did not differ significantly between the groups, administration of vitamin C improved the level of inflammation-related Lactococcus and JQ084893 to control levels. CONCLUSION: Vitamin C treatment provided moderate suppression of inflammation, proliferation, and certain inflammation-related dysbiosis in a murine model of colitis associated-early colon cancer. These findings support that vitamin C supplementation can benefit colonic health. Long-term clinical studies with various doses of vitamin C are warranted.

Abstract

BACKGROUD/OBJECTIVES: The objective of this study was to investigate the effects of vitamin C on inflammation, tumor development, and dysbiosis of intestinal microbiota in an azoxymethane (AOM)/dextran sulfate sodium (DSS)-induced inflammation-associated early colon cancer mouse model. MATERIALS/METHODS: Male BALB/c mice were injected intraperitoneally with AOM [10 mg/kg body weight (b.w)] and given two 7-d cycles of 2% DSS drinking water with a 14 d inter-cycle interval. Vitamin C (60 mg/kg b.w. and 120 mg/kg b.w.) was supplemented by gavage for 5 weeks starting 2 d after the AOM injection. RESULTS: The vitamin C treatment suppressed inflammatory morbidity, as reflected by disease activity index (DAI) in recovery phase and inhibited shortening of the colon, and reduced histological damage. In addition, vitamin C supplementation suppressed mRNA levels of pro-inflammatory mediators and cytokines, including cyclooxygenase-2, microsomal prostaglandin E synthase-2, tumor necrosis factor-α, Interleukin (IL)-1β, and IL-6, and reduced expression of the proliferation marker, proliferating cell nuclear antigen, compared to observations of AOM/DSS animals. Although the microbial composition did not differ significantly between the groups, administration of vitamin C improved the level of inflammation-related Lactococcus and JQ084893 to control levels. CONCLUSION: Vitamin C treatment provided moderate suppression of inflammation, proliferation, and certain inflammation-related dysbiosis in a murine model of colitis associated-early colon cancer. These findings support that vitamin C supplementation can benefit colonic health. Long-term clinical studies with various doses of vitamin C are warranted.

참고문헌 (68)

  1. Siegel RL, "Cancer statistics, 2016", CA Cancer J Clin, 66, pp.7~30 (2016)[DOI]
  2. Boyle P, "ABC of colorectal cancer: Epidemiology", BMJ, 321, pp.805~808 (2000)
  3. Bernstein CN, "Cancer risk in patients with inflammatory bowel disease: a population-based study", Cancer, 91, pp.854~862 (2001)[DOI]
  4. Itzkowitz SH, "Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation", Am J Physiol Gastrointest Liver Physiol, 287, pp.G7~G17 (2004)[DOI]
  5. Tanaka T, "Development of an inflammation-associated colorectal cancer model and its application for research on carcinogenesis and chemoprevention", Int J Inflam, 2012, pp.658786~ (2012)
  6. Meira LB, "DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice", J Clin Invest, 118, pp.2516~2525 (2008)
  7. Strober W, "Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases", Gastroenterology, 140, pp.1756~1767 (2011)
  8. Szkaradkiewicz A, "Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients", Arch Immunol Ther Exp (Warsz), 57, pp.291~294 (2009)
  9. Turnbaugh PJ, "The human microbiome project", Nature, 449, pp.804~810 (2007)[DOI]
  10. Laukens D, "Heterogeneity of the gut microbiome in mice: guidelines for optimizing experimental design", FEMS Microbiol Rev, 40, pp.117~132 (2016)[DOI]
  11. Kamada N, "Role of the gut microbiota in immunity and inflammatory disease", Nat Rev Immunol, 13, pp.321~335 (2013)[DOI]
  12. Holmes E, "Understanding the role of gut microbiome-host metabolic signal disruption in health and disease", Trends Microbiol, 19, pp.349~359 (2011)[DOI]
  13. Mai V, "Colonic bacterial flora: changing understandings in the molecular age", J Nutr, 134, pp.459~464 (2004)[DOI]
  14. Duenas M, "A survey of modulation of gut microbiota by dietary polyphenols", Biomed Res Int, 2015, pp.850902~ (2015)
  15. Biesalski HK, "Nutrition meets the microbiome: micronutrients and the microbiota", Ann N Y Acad Sci, 1372, pp.53~64 (2016)[DOI]
  16. Nishikimi M, "Molecular basis for the deficiency in humans of gulonolactone oxidase, a key enzyme for ascorbic acid biosynthesis", Am J Clin Nutr, 54, pp.1203~1208 (1991)[DOI]
  17. Jacob RA, "Vitamin C function and status in chronic disease", Nutr Clin Care, 5, pp.66~74 (2002)[DOI]
  18. Block G, "Vitamin C and cancer prevention: the epidemiologic evidence", Am J Clin Nutr, 53, pp.270~282 (1991)[DOI]
  19. Deicher R, "Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients", J Am Soc Nephrol, 16, pp.1811~1818 (2005)[DOI]
  20. Wang X, "Astaxanthin-rich algal meal and vitamin C inhibit Helicobacter pylori infection in BALB", cA mice, 2000, pp.44, 2452~2457
  21. Korantzopoulos P, "Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation", Int J Cardiol, 102, pp.321~326 (2005)[DOI]
  22. Kasetsuwan N, "Effect of topical ascorbic acid on free radical tissue damage and inflammatory cell influx in the cornea after excimer laser corneal surgery", Arch Ophthalmol, 117, pp.649~652 (1999)[DOI]
  23. Yan H, "Ascorbic acid ameliorates oxidative stress and inflammation in dextran sulfate sodiuminduced ulcerative colitis in mice", Int J Clin Exp Med, 8, pp.20245~20253 (2015)
  24. Remely M, "EGCG prevents high fat diet-induced changes in gut microbiota, decreases of DNA strand breaks, and changes in expression and DNA methylation of Dnmt1 and MLH1 in C57BL", 6J male mice, 2017, pp.2017, 3079148~
  25. Xu J, "Regulation of an antioxidant blend on intestinal redox status and major microbiota in early weaned piglets", Nutrition, 30, pp.584~589 (2014)[DOI]
  26. Chunhao Yu, "American ginseng attenuates azoxymethane", dextran sodium sulfate-induced colon carcinogenesis in mice, 2015, pp.39(1), 14~21[DOI]
  27. Kim KM, "Sasa quelpaertensis leaf extract suppresses dextran sulfate sodium-induced colitis in mice by inhibiting the proinflammatory mediators and mitogen-activated protein kinase phosphorylation", Nutr Res, 34, pp.894~905 (2014)[DOI]
  28. Okayasu I, "A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice", Gastroenterology, 98, pp.694~702 (1990)[DOI]
  29. Dieleman LA, "Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines", Clin Exp Immunol, 114, pp.385~391 (1998)[DOI]
  30. Araki A, "MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis", J Gastroenterol, 40, pp.16~23 (2005)[DOI]
  31. Wen XD, "Panax notoginseng attenuates experimental colitis in the azoxymethane", dextran sulfate sodium mouse model, 2014, pp.28, 892~898
  32. Sanchez-Fidalgo S, "Dietary extra virgin olive oil polyphenols supplementation modulates DSS-induced chronic colitis in mice", J Nutr Biochem, 24, pp.1401~1413 (2013)[DOI]
  33. Tanaka T, "A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate", Cancer Sci, 94, pp.965~973 (2003)[DOI]
  34. Wang D, "The role of COX-2 in intestinal inflammation and colorectal cancer", Oncogene, 29, pp.781~788 (2010)
  35. Sheibanie AF, "The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23-->IL-17 axis", J Immunol, 178, pp.8138~8147 (2007)[DOI]
  36. Wang D, "Prostaglandins and cancer", Gut, 55, pp.115~122 (2006)[DOI]
  37. Gudis K, "Microsomal prostaglandin E synthase (mPGES)-1, mPGES-2 and cytosolic PGES expression in human gastritis and gastric ulcer tissue", Lab Invest, 85, pp.225~236 (2005)[DOI]
  38. Murakami M, "Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2", J Biol Chem, 278, pp.37937~37947 (2003)[DOI]
  39. Meduri GU, "Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time", Chest, 107, pp.1062~1073 (1995)[DOI]
  40. Hartel C, "Effects of vitamin C on intracytoplasmic cytokine production in human whole blood monocytes and lymphocytes", Cytokine, 27, pp.101~106 (2004)[DOI]
  41. Jung IK, "Prognostic significance of proliferating cell nuclear antigen (PCNA) expression in patients with colorectal carcinoma", J Korean Cancer Assoc, 27, pp.550~558 (1995)
  42. Suzuki R, "Dose-dependent promoting effect of dextran sodium sulfate on mouse colon carcinogenesis initiated with azoxymethane", Histol Histopathol, 20, pp.483~492 (2005)
  43. De Robertis M, "The AOM", DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies, 2011, pp.10, 9~
  44. Onodera H, "Pathologic significance of tumor progression in locally recurrent rectal cancer: different nature from primary cancer", Dis Colon Rectum, 43, pp.775~781 (2000)[DOI]
  45. Jackson PE, "Associations between tissue-specific DNA alkylation, DNA repair and cell proliferation in the colon and colon tumour yield in mice treated with 1,2-dimethylhydrazine", Carcinogenesis, 24, pp.527~533 (2003)[DOI]
  46. Bussey HJ, "A randomized trial of ascorbic acid in polyposis coli", Cancer, 50, pp.1434~1439 (1982)
  47. Jacobs EJ, "Vitamin C and vitamin E supplement use and colorectal cancer mortality in a large American Cancer Society cohort", Cancer Epidemiol Biomarkers Prev, 10, pp.17~23 (2001)
  48. Cahill RJ, "Effects of vitamin antioxidant supplementation on cell kinetics of patients with adenomatous polyps", Gut, 34, pp.963~967 (1993)[DOI]
  49. Reagan-Shaw S, "Dose translation from animal to human studies revisited", FASEB J, 22, pp.659~661 (2008)
  50. Levine M, "Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance", Proc Natl Acad Sci U S A, 93, pp.3704~3709 (1996)[DOI]
  51. Carr AC, "Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans", Am J Clin Nutr, 69, pp.1086~1107 (1999)
  52. Jenab M, "Plasma and dietary vitamin C levels and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST)", Carcinogenesis, 27, pp.2250~2257 (2006)[DOI]
  53. Strnadova E, "Changes in ascorbic acid content in various organs and serum of mice experimentally infected with Taenia crassiceps (Zeder, 1800) cysticerci", Folia Parasitol (Praha), 32, pp.185~188 (1985)
  54. Mosca A, "Gut microbiota diversity and human diseases: should we reintroduce key predators in our ecosystem?", Front Microbiol, 7, pp.455~ (2016)
  55. Louis P, "The gut microbiota, bacterial metabolites and colorectal cancer", Nat Rev Microbiol, 12, pp.661~672 (2014)
  56. Ott SJ, "Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease", Gut, 53, pp.685~693 (2004)[DOI]
  57. Claesson MJ, "Gut microbiota composition correlates with diet and health in the elderly", Nature, 488, pp.178~184 (2012)[DOI]
  58. Ahn J, "Human gut microbiome and risk for colorectal cancer", J Natl Cancer Inst, 105, pp.1907~1911 (2013)[DOI]
  59. Zackular JP, "The gut microbiome modulates colon tumorigenesis", MBio, 4, pp.692~613 (2013)
  60. Berry D, "Intestinal microbiota signatures associated with inflammation history in mice experiencing recurring colitis", Front Microbiol, 6, pp.1408~ (2015)
  61. Yeom Y, "Sasa quelpaertensis leaf extract regulates microbial dysbiosis by modulating the composition and diversity of the microbiota in dextran sulfate sodium-induced colitis mice", BMC Complement Altern Med, 16, pp.481~ (2016)[DOI]
  62. Chen HM, "Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma", Am J Clin Nutr, 97, pp.1044~1052 (2013)[DOI]
  63. Morrison DJ, "Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism", Gut Microbes, 7, pp.189~200 (2016)[DOI]
  64. Hemarajata P, "Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation", Therap Adv Gastroenterol, 6, pp.39~51 (2013)[DOI]
  65. de Moreno de LeBlanc A, "Oral administration of a catalaseproducing Lactococcus lactis can prevent a chemically induced colon cancer in mice", J Med Microbiol, 57, pp.100~105 (2008)[DOI]
  66. David LA, "Diet rapidly and reproducibly alters the human gut microbiome", Nature, 505, pp.559~563 (2014)[DOI]
  67. Willing BP, "A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes", Gastroenterology, 139, pp.1844~1854 (2010)[DOI]
  68. Lozupone CA, "Diversity, stability and resilience of the human gut microbiota", Nature, 489, pp.220~230 (2012)[DOI]

관련 논문AI추천

Açaí Berries Inhibit Colon Tumorigenesis in Azoxymethane/Dextran Sulfate Sodium-Treated Mice김나영, 남령희, 서영준, 이동호, 이선민, 이하나, 이혜승, 최윤정, 최윤진거트앤리버 소화기연관학회협의회 · Gut and Liver2017 · 제11권 제2호Increase in dietary protein content exacerbates colonic inflammation and tumorigenesis in azoxymethane-induced mouse colon carcinogenesis김은정, 안은영, 탁가희한국영양학회 · Nutrition Research and Practice2017 · 제11권 제4호Sex differences of β-carotene effects in azoxymethane/dextran sulfate sodium-induced early colorectal cancer mice김유리, 한혜진, Sejin Park, Soyeon Han한국영양학회 · Nutrition Research and Practice2025 · 제19권 제6호Differential effects of various dietary proteins on dextran sulfate sodium-induced colitis in mice김은정, Ahn Eunyeong, Jeong Hyejin한국영양학회 · Nutrition Research and Practice2022 · 제16권 제6호Effect of Estradiol in an Azoxymethane/Dextran Sulfate Sodium-Treated Mouse Model of Colorectal Cancer: Implication for Sex Difference in Colorectal Cancer Development신은, 김나영, 김주성, 나희영, 남령희, 박지현, 서영준, 손성화, 손희진, 송진희, 이동호, 이선민, 이하나대한암학회 · Cancer Research and Treatment2019 · 제51권 제2호Effects of Micro- and Nano-sized Iron Particles on Colonic Pre-neoplastic Lesions in an Experimental Mouse Model김대현, 김종수, 남상윤, 윤영원, 이범준자연과학연구소 · Quantitative Bio-Science2015 · 제34권 제2호

이 간행물의 다른 논문 (10건)